- Report
- January 2024
- 213 Pages
Global
From €4421EUR$4,650USD£3,714GBP
- Report
- October 2022
- 194 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- April 2020
- 108 Pages
Global
From €1141EUR$1,200USD£958GBP
- Report
- April 2019
- 73 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- April 2023
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- October 2024
- 80 Pages
Vietnam
From €3422EUR$3,600USD£2,875GBP
- Report
- January 2024
- 155 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- January 2024
- 199 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- January 2025
- 73 Pages
From €3280EUR$3,450USD£2,755GBP
- Report
- July 2024
- 91 Pages
From €3280EUR$3,450USD£2,755GBP
- Report
- November 2023
- 30 Pages
Global
From €2614EUR$2,750USD£2,196GBP
- Report
- November 2023
- 30 Pages
Global
From €3090EUR$3,250USD£2,596GBP
- Report
- May 2023
- 147 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3327EUR$3,500USD£2,795GBP
- Report
- September 2024
- 82 Pages
Japan
From €3327EUR$3,500USD£2,795GBP
- Report
- November 2023
- 190 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- October 2023
- 189 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- October 2023
- 181 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- October 2023
- 178 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- January 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP

The Vaccine Adjuvant market is a subset of the Vaccines market, which is composed of products that are used to enhance the effectiveness of vaccines. Vaccine adjuvants are substances that are added to vaccines to increase the body's immune response to the vaccine. Adjuvants can be either natural or synthetic, and can be used to increase the potency of a vaccine, reduce the amount of antigen needed, or to extend the duration of the vaccine's effectiveness. Vaccine adjuvants are used in a variety of vaccines, including those for influenza, hepatitis, and human papillomavirus.
Some companies in the Vaccine Adjuvant market include GlaxoSmithKline, Merck, Sanofi, and Novartis. Show Less Read more